William L. Macias Immunovant, Inc. (IMVT) insider trading activity

William L. Macias is Chief Medical Officer of Immunovant, Inc.. Currently has a direct ownership of 365,144 shares of IMVT, which is worth approximately $10 Million. The most recent transaction as insider was on Oct 16, 2024, when has been sold 3,188 shares (Common Stock) at a price of $28.79 per share, resulting in proceeds of $91,782. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 365K

1.67% 3M change

8.4% 12M change

Total Value Held $10 Million

William L. Macias Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 16 2024	SELL Open market or private sale	$91,782 $28.79 p/Share	3,188 Reduced 0.87%	365,144 Common Stock
Aug 21 2024	SELL Open market or private sale	$97,106 $32.08 p/Share	3,027 Reduced 0.82%	368,332 Common Stock
Jul 17 2024	SELL Open market or private sale	$91,593 $30.09 p/Share	3,044 Reduced 0.81%	371,359 Common Stock
May 22 2024	SELL Open market or private sale	$96,273 $29.65 p/Share	3,247 Reduced 0.86%	374,403 Common Stock
Apr 17 2024	SELL Open market or private sale	$243,183 $29.37 p/Share	8,280 Reduced 2.15%	377,650 Common Stock
Apr 02 2024	BUY Grant, award, or other acquisition	-	54,978 Added 12.47%	385,930 Common Stock
Feb 22 2024	SELL Open market or private sale	$80,289 $36.15 p/Share	2,221 Reduced 0.67%	330,952 Common Stock
Jan 18 2024	SELL Open market or private sale	$17,396 $41.03 p/Share	424 Reduced 0.13%	333,173 Common Stock
Nov 22 2023	SELL Open market or private sale	$108,202 $33.14 p/Share	3,265 Reduced 0.97%	333,597 Common Stock
Oct 19 2023	SELL Open market or private sale	$19,504 $36.8 p/Share	530 Reduced 0.16%	336,862 Common Stock
Aug 24 2023	SELL Open market or private sale	$253,936 $20.59 p/Share	12,333 Reduced 3.53%	337,392 Common Stock
Jul 19 2023	SELL Open market or private sale	$10,624 $24.94 p/Share	426 Reduced 0.12%	349,725 Common Stock
Apr 25 2023	SELL Open market or private sale	$8,291 $16.29 p/Share	509 Reduced 0.15%	350,151 Common Stock
Apr 12 2023	BUY Grant, award, or other acquisition	-	87,664 Added 20.0%	350,660 Common Stock
Feb 02 2023	SELL Open market or private sale	$9,794 $18.24 p/Share	537 Reduced 0.2%	262,996 Common Stock
Jan 11 2023	SELL Open market or private sale	$709,968 $15.93 p/Share	44,568 Reduced 14.47%	263,533 Common Stock
Oct 21 2022	SELL Open market or private sale	$3,297 $9.67 p/Share	341 Reduced 0.11%	308,101 Common Stock
Aug 17 2022	BUY Grant, award, or other acquisition	-	112,816 Added 26.78%	308,442 Common Stock
Jul 22 2022	SELL Open market or private sale	$1,513 $4.7 p/Share	322 Reduced 0.16%	195,626 Common Stock
Apr 19 2022	SELL Open market or private sale	$6,932 $4.98 p/Share	1,392 Reduced 0.71%	195,948 Common Stock
Jan 05 2022	SELL Open market or private sale	$222,012 $8.28 p/Share	26,813 Reduced 11.96%	197,340 Common Stock
Nov 05 2021	BUY Grant, award, or other acquisition	-	112,108 Added 33.34%	224,153 Common Stock
Jun 11 2021	BUY Grant, award, or other acquisition	-	112,045 Added 50.0%	112,045 Common Stock

WLM

William L. Macias

Chief Medical Officer

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMVT shares.

Notify only if

Value

Insider Trading

Get notified when an Immunovant, Inc. insider buys or sells IMVT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Immunovant, Inc.

Track Activities on IMVT

Account